Metraipolis › archive › dc_025ccb355fa0

DDX5 (p68) and UbE2T as emerging superior cancer therapeutic targets: dual molecular glue target degradation by FL118 for conquering difficult-to-treat cancers — Europe PMC PMID:42152107

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42152107
DOI: 10.1186/s13046-[numero omesso]-3
License (as archived): solo-consultazione
Archived: 2026-11-01T15:40:13.013Z
SHA-256 of the archived text: d88cf82977266ebc560045facc32029c8edbaf840c9d955a1d7c4e919744b05e
Stable URL of this page: https://metraipolis.com/documento/dc_025ccb355fa0

How to cite

DDX5 (p68) and UbE2T as emerging superior cancer therapeutic targets: dual molecular glue target degradation by FL118 for conquering difficult-to-treat cancers — Europe PMC PMID:42152107 — Europe PMC (en), https://europepmc.org/article/MED/42152107 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_025ccb355fa0 (Metraipolis archive dc_025ccb355fa0, sha256 d88cf82977266ebc560045facc32029c8edbaf840c9d955a1d7c4e919744b05e)

BibTeX

@misc{dc025ccb355fa0,
  title = {DDX5 (p68) and UbE2T as emerging superior cancer therapeutic targets: dual molecular glue target degradation by FL118 for conquering difficult-to-treat cancers — Europe PMC PMID:42152107},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42152107},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_025ccb355fa0; sha256 d88cf82977266ebc560045facc32029c8edbaf840c9d955a1d7c4e919744b05e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42152107. Agents can read the archived copy with the MCP tool read_document.